We're suing NIH, DOGE, and RFK Jr. for censoring research

CSPI is part of a class action lawsuit against NIH, HHS, and DOGE, challenging censorship of crucial research grants. Learn how to help defend public health.

Phthalates: FDA

CSPI and other public interest groups filed lawsuits seeking to force FDA to decide whether to ban phthalates in food packaging and processing materials.

NIH censors crucial research in Alzheimer's, kidney disease, & more, researchers share

NIH is targeting and terminating grants for research studies that it thinks will communicate disfavored viewpoints on diversity, gender identity, climate change, and more, violating First Amendment rights and threatening the future of public health.

Research Censorship at NIH

On Sep. 16, 2026, CSPI’s Litigation Department and its co-counsel at the ACLU, Protect Democracy, and Jacobson Lawyers Group sued the National Institutes of Health (NIH), the US Department of Health and Human Services (HHS), and the US DOGE Service, challenging NIH’s ideologically driven censorship and termination of biomedical research grants.

Salles v. NIH Complaint (9/16/26)

On Sep. 16, 2026, CSPI’s Litigation Department and its co-counsel at the ACLU, Protect Democracy, and Jacobson Lawyers Group sued the National Institutes of Health (NIH), the US Department of Health and Human Services (HHS), and the US DOGE Service (DOGE), challenging NIH’s ideologically driven censorship and termination of biomedical research grants.

Coverage for FDA-Approved Contraceptives: U.S. Court of Appeals for the Third Circuit amicus brief

In March 2026, CSPI’s Litigation Department took a stand for scientific integrity and public health, filing an amicus brief to challenge a Trump Administration Rule that threatens to deny tens of thousands of women access to FDA-approved contraceptives under their employer-sponsored health plans. The brief, which was filed on behalf of three former FDA officials, addresses the misleading and cherry-picked data cited by the Administration, as well as the rigorous science that goes into vetting FDA-approved contraceptives.

Trump administration distorting science on safety of FDA-approved contraception, former FDA officials tell Appeals Court

Amicus brief from Drs. Hamburg, Ostroff, and Lurie supporting Pennsylvania and New Jersey’s efforts to preserve insurance coverage for contraceptives

NIH Agrees to Evaluate and Complete Review on Stalled Scientific Grant Applications

CSPI in 2025: Advancing food safety & public health for all

Your support helped CSPI’s efforts to ban harmful food additives, safeguard infant foods, improve retail policies, and restore funds for scientific research. Thank you for making 2025 a healthier year for all!